TVRD Tvardi Therapeutics, Inc.

$2.63 +1.94%

Healthcare · Pharmaceutical Preparations

Tvardi Therapeutics, Inc. (TVRD) is a healthcare company in the Pharmaceutical Preparations industry, with a market capitalization of $25 million. Shares last traded at $2.63, 94.0% below their 52-week high. Over the past year the stock is down 89.5%. Net profit margin is -255.1%, below the peer median of -0.1%. Revenue declined 66.0% year over year.

Market Cap

$25M

Shares Out

9.4M

EPS (TTM)

$-8.99

P/E Ratio

—

P/S Ratio

3.46

P/B Ratio

1.70

Dividend / Share

—

Dividend Yield

—

52-Week High

$43.56

52-Week Low

$2.48

Volume

3,115

Avg Vol (3m)

2,055.698

Performance

-1.50%

-28.73%

-28.34%

-37.23%

YTD

-35.22%

-89.47%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

31.41

SMA (50)

$3.29

SMA (200)

$8.45

Price vs SMA50

-20.11%

Price vs SMA200

-68.87%

ATR (14)

$0.20

Financials

Revenue

$7M

Net Income

$-18M

Gross Margin

—

Operating Margin

-374.8%

Net Margin

-255.1%

Return on Equity

-125.5%

Return on Assets

-70.5%

Current Ratio

2.25

Debt / Equity

0.78

Revenue Growth (YoY)

-66.0%

Latest reported annual period ending 2024-12-31 · SEC EDGAR/XBRL.

Recent earnings

Period	EPS (diluted)	Reported
Q1 2026	$-0.73	2026-05-08
FY 2025	$-3.26	2026-03-31
Q3 2025	$-2.50	2025-11-13
Q2 2025	$-2.04	2025-08-14
Q1 2026	$-3.72	2026-05-08
FY 2025	$-11.42	2026-03-31

Full earnings history →

Pharmaceutical Preparations peers

TVRD vs 14 industry peers (Pharmaceutical Preparations), by market cap.

P/S vs peers

3.46 / 3.54 med

-2% discount

Net margin vs peers

-255.1% / -0.1% med

below median

1–14 of 14


LLY	Lilly (Eli)	$1.04T	50.16	15.88	31.7%	-1.17%
JNJ	Johnson & Johnson	$549.8B	20.51	5.84	28.5%	-2.42%
ONC	Beone Medicines Ltd.	$390.6B	1361.26	73.10	5.4%	+2.83%
ABBV	AbbVie	$382.5B	90.51	6.25	6.9%	-2.16%
MRK	Merck	$281.6B	15.43	4.33	28.1%	-1.30%
ABT	Abbott Laboratories	$154.3B	23.65	3.48	14.7%	+0.09%
PFE	Pfizer	$143.7B	18.50	2.30	12.4%	-2.89%
VRTX	Vertex Pharmaceuticals	$114.6B	28.99	9.55	32.9%	-1.63%
BMY	Bristol Myers Squibb	$110.3B	15.63	2.29	14.6%	-2.35%
REGN	Regeneron Pharmaceuticals	$63.4B	14.08	4.42	31.4%	+0.38%
ALNY	Alnylam Pharmaceuticals	$36.9B	117.57	9.93	8.4%	-1.66%
TEVA	Teva Pharmaceutical Industries Ltd	$36.6B	25.98	2.12	8.2%	-3.33%
ZTS	Zoetis	$33.1B	12.37	3.49	28.2%	+2.09%
RPRX	Royalty Pharma Plc	$23.1B	30.02	9.73	32.4%	-1.30%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.